s6y
Company name or ticker
Search
Tempest Therapeutics, Inc.
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Filed
Monday, November 19, 2018
Accession number
0001104659-18-069212
Documents
8-K
425
On sec.gov
Filing index
All files
Complete submission text
SGML header